TerminatedNCT06052371
Project VerioVue Enhancements - Neonate Study
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- LifeScan Scotland Ltd
- Principal Investigator
- Nicola Zammitt, MBCHBEdinburgh Centre for Endocrinology and Diabetes
- Intervention
- VerioVue (Enhancements) blood glucose monitoring system(device)
- Enrollment
- 99 target
- Eligibility
- All sexes
- Timeline
- 2023 – 2023
Study locations (3)
- Whipps Cross University Hospital (Barts Health NHS Trust), London, United Kingdom
- Queens Hospital Romford (BHRUT), London, United Kingdom
- The Royal Oldham Hospital (Northern Care Alliance NHS Foundation Trust), Manchester, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06052371 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.